In Brief: International Murex
This article was originally published in The Gray Sheet
Executive Summary
International Murex: Launches five new rapid diagnostic test kits to U.S. clinical reference and hospital laboratories. The company says that the five products, recently cleared by FDA, include kits to "assist in the detection of antibodies to: infectious mononucleosis, group A streptococcus [and] rheumatoid arthritis (two tests)," as well as a test to detect C-reactive protein. The kits, which can provide both qualitative and semiqualitative results, "require no instrumentation," provide results "between 2 and 10 minutes" and "are all equipped with disposable slides that minimize the risk of contamination." The combined market for the new test kits is about $20 mil., Murex estimates...
You may also be interested in...
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.